The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[(E)-4-methoxy-benzenesulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester ID: ALA208987
PubChem CID: 24205067
Max Phase: Preclinical
Molecular Formula: C15H16N6O3S5
Molecular Weight: 488.67
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(S(=O)(=O)NC2=NCCN2C(=S)SN2CCn3c2nsc3=S)cc1
Standard InChI: InChI=1S/C15H16N6O3S5/c1-24-10-2-4-11(5-3-10)29(22,23)18-12-16-6-7-19(12)15(26)28-21-9-8-20-13(21)17-27-14(20)25/h2-5H,6-9H2,1H3,(H,16,18)
Standard InChI Key: WAGGPKJMAYNWJX-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
1.4130 -5.4660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1856 -5.7630 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
2.7049 -5.1220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4584 -4.6448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2571 -4.4288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.2986 -3.6037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5259 -3.3068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0066 -3.9516 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5300 -5.1636 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.1855 -3.9062 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-0.2298 -3.1928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0527 -3.1928 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1855 -2.4794 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.5391 -2.5264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3243 -2.7814 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3243 -3.6043 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5391 -3.8592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2840 -4.6444 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.8706 -5.2310 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.2840 -5.8137 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4533 -4.6444 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.4533 -5.8137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2460 -5.5989 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8284 -6.1808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.6153 -6.9778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.8146 -7.1896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.2355 -6.6061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1963 -7.5603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9823 -8.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6 7 1 0
7 8 1 0
8 4 1 0
3 9 2 0
8 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 12 1 0
17 18 1 0
18 19 1 0
19 20 2 0
19 21 2 0
19 22 1 0
22 23 2 0
1 2 1 0
23 24 1 0
2 3 1 0
24 25 2 0
3 5 1 0
25 26 1 0
4 1 2 0
26 27 2 0
27 22 1 0
4 5 1 0
25 28 1 0
5 6 1 0
28 29 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 488.67Molecular Weight (Monoisotopic): 487.9887AlogP: 2.09#Rotatable Bonds: 4Polar Surface Area: 92.06Molecular Species: NEUTRALHBA: 11HBD: 1#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.03CX Basic pKa: 1.68CX LogP: 3.61CX LogD: 3.61Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -1.46
References 1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M.. (2006) Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides., 16 (14): [PMID:16682194 ] [10.1016/j.bmcl.2006.04.067 ]